Investigational Drug Beats Standard Therapy in Hepatitis C Study

June 17th, 2008 by admin

A Phase IIa effort work manifold compounding therapy with PEGASYS, COPEGUS and Roche’s investigational take R1626, demonstrated a higher salutation evaluate than tralatitious compounding therapy alone. While R1626’s power and broad obstruction to status makes it a crowning Hepatitis C…

Posted in Hepatology |

Related posts

Comments are closed.